SODIUM LACTATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Lactate, and when can generic versions of Sodium Lactate launch?
Sodium Lactate is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in five NDAs.
The generic ingredient in SODIUM LACTATE is sodium lactate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium lactate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM LACTATE?
- What are the global sales for SODIUM LACTATE?
- What is Average Wholesale Price for SODIUM LACTATE?
Summary for SODIUM LACTATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| DailyMed Link: | SODIUM LACTATE at DailyMed |
Recent Clinical Trials for SODIUM LACTATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Los Angeles | PHASE2 |
| University of Pittsburgh | PHASE4 |
| Fundacin Cardioinfantil Instituto de Cardiologa | PHASE4 |

